Netflix’s latest Korean blockbuster The Great Flood has surged to the top of the platform’s global charts for nonglobal films, but audiences are divided over its cryptic ending and philosophical twist ...
The afterlife rom-com/fantasy movie Eternity asks a fairly simple question: Which of the two husbands a 90-something woman married during her lifetime is more important to her, the man she lived with ...
This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Claire Danes and Matthew Rhys, our jaws are on the floor at that wild and tumultuous finale of The Beast in Me. **Spoilers ahead for the Season 1 finale, now streaming on Netflix** While we as the ...
Netflix's latest “Frankenstein” adaptation is one of the most celebrated yet. In this article, we're recapping everything that occurred and answering the question, ‘What happened at the end of ...
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...
SPOILER ALERT: This story contains spoilers for the first two episodes of “Pluribus,” streaming now on Apple TV. Not only did “Breaking Bad” earn four more seasons that cemented it as one of the ...
Guillermo Del Toro’s Frankenstein is now out on Netflix, with the monster (played by Jacob Elordi) shown to be far more human than his titular creator. The ending of the Netflix film differs from both ...
Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results